Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX   US23283K1051

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
0.65(c) 0.7318(c) 0.72(c) 1.13(c) 1.197 Last
5 177 914 17 326 551 4 211 677 44 480 764 25 113 857 Volume
+18.18% +12.58% -1.61% +56.94% +5.93% Change
More quotes
Company
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects.It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device,... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
03/04 | 08:40amPresentation
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 8,96 M
EBIT 2014 -31,5 M
Net income 2014 -35,5 M
Debt 2014 -
Yield 2014 -
Sales 2015 16,5 M
EBIT 2015 -26,9 M
Net income 2015 -30,1 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 11,7x
Capi. / Sales 2015 6,35x
Capitalization 104 M
More Financials
Latest news on CYTORI THERAPEUTICS INC
02:26a CYTORI THERAPEUTICS : Secures Positive European Opinion on Orphan Drug Status
02/26 CYTORI THERAPEUTICS : FDA Approves Expansion of Pivotal Scleroderma STAR Trial t..
02/24 CYTORI THERAPEUTICS : Receives Positive European Opinion on Orphan Drug Status
02/23 MONDAY SECTOR LEADERS : Drugs, Biotechnology Stocks
02/21 CYTORI THERAPEUTICS : Starts Enrollment in ACT-OA: US Phase II Trial for Knee Os..
02/20 CYTORI THERAPEUTICS : Trademark Application for "CELASE" Filed by Cytori Therape..
02/19 CYTORI THERAPEUTICS : Enrollment Begins European Knee Meniscus Injury Pilot Tria..
02/19 CYTORI THERAPEUTICS : Starts Enrollment in ACT-OA: US Phase II Trial for Knee Os..
More news
Sector news Medical Equipment, Supplies & Distribution - NEC
09:11a ST JUDE MEDICAL : to Present at the Barclays Global Healthcare Conference
09:01a MEDTRONIC : Announces Irish High Court Approval of Share Premium Reduction
08:27a ST JUDE MEDICAL : to pay $14.25 million in Riata lawsuits
Plus d'actualités du secteur Medical Equipment, Supplies & Distribution - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF